lanreotide

SynDRA canonical compound SYN0041796 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	SSTR2 \| SSTR3 \| SSTR5
Mechanism of action	somatostatin receptor agonist
Indication	acromegaly
Disease area	endocrinology

All known targets

SSTR2
SSTR3
SSTR5
SSTR1
SSTR4
Sstr2
Sstr3
Sstr5

Mechanisms of action (all sources)

somatostatin receptor agonist
SSTR2 MODULATOR
SSTR2 AGONIST
SSTR5 AGONIST

Drug classes

Somatostatin Receptor Agonists
Antineoplastic Agents
Somatostatin Analog

ATC classes

HYPOTHALAMIC HORMONES

Cross-references

PubChem CID: 71349
ChEMBL: CHEMBL1201185
DrugBank: DB06791
ChEBI: CHEBI:135901
KEGG: D04666
RxNorm: 68092
TTD: D0M2YE

Synonyms

LANREOTIDE ACETATE
SOMATULINE DEPOT
Somatuline
angiopeptin
ipstyl
lanreotide autogel
somatulin-autogel
somatuline
lanreotide acetate
Lanreotide acetate
Angiopeptin acetate
Somatulin
DC 13-116
Autogel
Bim-23014
Lanreotide [INN:BAN]
Lanreotidum [INN-Latin]
Lanreotida [INN-Spanish]
Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2
Somatuline lp (TN)
Lanreotide Autogel
CHEBI:135901
GLXC-15339
H-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2
Lanreotida
Angiopeptin
Somatuline autogel
Somatuline la

Look up lanreotide in the interactive SynDRA portal →